ONCY: Another risky biotech to consider

Long term downtrend line broken. V shaped upswing with much increased volume. It has a well patented potential product that has great promise in assisting in treatment of difficult cancers. Like all small biotech companies there is often a lot of volatility and risk. I'm looking for a rise to 9-15. Yesterday jump due to Buy rating with target of 15 by HC Wainwright & Co
www.benzinga.com/stock/oncy

More info at : seekingalpha.com/art...ancer-player-in-2020